159 related articles for article (PubMed ID: 8902649)
21. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
22. Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis.
Inoh M; Tokuda M; Kiuchi H; Kurata N; Takahara J
Arthritis Rheum; 1996 Feb; 39(2):287-91. PubMed ID: 8849381
[TBL] [Abstract][Full Text] [Related]
23. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W
Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409
[TBL] [Abstract][Full Text] [Related]
24. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
Kambayashi J; Sakon M; Yokota M; Shiba E; Kawasaki T; Mori T
Thromb Res; 1990 Oct; 60(2):157-67. PubMed ID: 2149215
[TBL] [Abstract][Full Text] [Related]
25. Alterations in coagulation and fibrinolysis during sepsis.
Kidokoro A; Iba T; Fukunaga M; Yagi Y
Shock; 1996 Mar; 5(3):223-8. PubMed ID: 8696988
[TBL] [Abstract][Full Text] [Related]
26. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
27. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
28. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
Geenen RW; Delaere KP; van Wersch JW
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
[TBL] [Abstract][Full Text] [Related]
29. Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies.
Hayashi M; Fukasawa I; Inaba N
Int J Clin Pract; 2006 Oct; 60(10):1244-9. PubMed ID: 16669831
[TBL] [Abstract][Full Text] [Related]
30. Is there circadian variation of plasma endothelin (ET-1) in patients with systemic scleroderma (SSc)?
Maeda M; Kachi H; Takagi H; Kitajima Y
J Dermatol Sci; 1997 Nov; 16(1):38-44. PubMed ID: 9438906
[TBL] [Abstract][Full Text] [Related]
31. Blood coagulation and fibrinolysis in eclamptic patients and their correlation with the clinical signs.
Halim A; Bhuiyan AB; Azim FA; Khatun S; Kanayama N; el Maradny E; Maehara K; Hiroshi K; Terao T
Gynecol Obstet Invest; 1995; 39(2):97-102. PubMed ID: 7772198
[TBL] [Abstract][Full Text] [Related]
32. Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis.
Homma S; Masunaga Y; Kurosu M; Inoue M; Sakurai T; Asano Y
Perit Dial Int; 2002; 22(2):178-83. PubMed ID: 11990401
[TBL] [Abstract][Full Text] [Related]
33. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
34. Abnormalities of blood coagulation and fibrinolysis in psoriasis.
Marongiu F; Sorano GG; Bibbò C; Pistis MP; Conti M; Mulas P; Balestrieri A; Biggio P
Dermatology; 1994; 189(1):32-7. PubMed ID: 7516205
[TBL] [Abstract][Full Text] [Related]
35. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
36. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?
Marongiu F; Conti M; Mameli G; Sorano GG; Cossu E; Cirillo R; Balestrieri A
Thromb Res; 1990 Apr; 58(2):91-9. PubMed ID: 1693451
[TBL] [Abstract][Full Text] [Related]
37. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
Fujiwara Y; Tagami S; Kawakami Y
J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
[TBL] [Abstract][Full Text] [Related]
38. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects.
Weiss C; Seitel G; Bärtsch P
Med Sci Sports Exerc; 1998 Feb; 30(2):246-51. PubMed ID: 9502353
[TBL] [Abstract][Full Text] [Related]
39. Plasma parameters of the prothrombotic state in chronic uremia.
Sagripanti A; Cupisti A; Baicchi U; Ferdeghini M; Morelli E; Barsotti G
Nephron; 1993; 63(3):273-8. PubMed ID: 8446263
[TBL] [Abstract][Full Text] [Related]
40. Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Yamashita T; Nomoto K; Tahara M; Atsuchi Y
Int J Cardiol; 1994 Dec; 47(1 Suppl):S7-12. PubMed ID: 7737755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
